Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis-Reference-Cited by-同舟云学术

Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis

Published:2020-12 Issue:12 Volume:1865 Page:158792
ISSN:1388-1981
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Author:

Emma Maria R.,Giannitrapani Lydia,Cabibi Daniela,Porcasi Rossana,Pantuso Gianni,Augello Giuseppa,Giglio Rosaria V.,Re Noemi Lo,Capitano Adele R.,Montalto Giuseppe,Soresi Maurizio,Cervello Melchiorre

Funder

Fondazione AIRC per la Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference37 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis Society;Soresi;Acta Diabetol.,2013

3. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis;Anstee;Nat. Rev. Gastroenterol. Hepatol.,2013

4. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases;Motamed;Clin. Res. Hepatol. Gastroenterol.,2017

5. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD);Buzzetti;Metabolism.,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy;Medical Oncology;2024-07-15

2. A promising therapy for fatty liver disease: PCSK9 inhibitors;Phytomedicine;2024-06

3. Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome;European Cardiology Review;2024-05-09

4. Metabolic dysfunction-associated steatotic liver disease: An opportunity for collaboration between cardiology and hepatology;Atherosclerosis;2024-05

5. Atherosclerosis and Toll-Like Receptor4 (TLR4), Lectin-Like Oxidized Low-Density Lipoprotein-1 (LOX-1), and Proprotein Convertase Subtilisin/Kexin Type9 (PCSK9);Mediators of Inflammation;2024-02-27